Hey guys,
I got a question regarding my dad.
He was diagnosed in summer 2022 with stage 4, Gleason 4+4, PSA of 122 and many osteoblastic bone metastases throughout the whole skeleton (very high volume) He did the triplet therapy, which lowered his PSA to 0.4 (January 2023). Scans afterwards stated that the metastases are still there, but a little bit decreased in activeness.
Since then, he still gets his 3month Lupron shot, Xgeva and daily Zytiga (2x500mg and 5mg Prednison). The PSA declined further in 2023 every time it got measured and is now around ~0.03. During the summer he had no pain and one could forget that he has this terminal illness. In the last few months the pain, especially in the pelvic and the lower back, reoccured, more during the night, but also during the daytime here and there. A new MRI of the pelvic indicated that all metastases are still there and have become more sclerotic compared with the scans of 2022 (which regarding osteoblastic metastases I think isn't a good thing?). In the last session his doctor adviced him to increase the Predinsolon to 10mg because now he is mCRPC. He accepted this during the meeting, but afterwards didn't really unterstand why he was seen as castration resistant now despite the ever decreasing PSA. Could the doctor classify him as castration resistant just because of the result of the MRI? It's a bit until the next meeting with the doctor, so maybe someone here has some advice or a similar experience?
Thanks in advance for reading